Deka Bank Deutsche Girozentrale Sage Therapeutics, Inc. Transaction History

Deka Bank Deutsche Girozentrale

$53.9 Billion
Q3 2024

A detailed history of Deka Bank Deutsche Girozentrale transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 22,220 shares of SAGE stock, worth $121,543. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,220

Previous 22,220 -0.0%

Holding current value

$121,543

Previous $236,000 32.2%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	BUY	$30.71 - $45.71 $13,819 - $20,569	450 Added 2.07%	22,220 $762,000
Q4 2021 Feb 02, 2022	BUY	$37.06 - $47.11 $18,530 - $23,555	500 Added 2.35%	21,770 $913,000
Q1 2021 Apr 28, 2021	BUY	$70.65 - $96.76 $109,507 - $149,978	1,550 Added 7.86%	21,270 $1.54 Million
Q4 2020 Mar 12, 2021	SELL	$58.41 - $89.06 $58,410 - $89,060	-1,000 Reduced 4.83%	19,720 $1.7 Million
Q3 2020 Oct 29, 2020	BUY	$41.13 - $62.45 $852,213 - $1.29 Million	20,720 New	20,720 $1.21 Million
Q1 2020 May 14, 2020	SELL	$26.15 - $77.24 $26,960 - $79,634	-1,031 Closed	0 $0
Q4 2019 Feb 04, 2020	SELL	$60.18 - $154.77 $1.26 Million - $3.24 Million	-20,920 Reduced 95.3%	1,031 $75,000
Q3 2019 Nov 14, 2019	SELL	$140.29 - $189.96 $3.41 Million - $4.61 Million	-24,280 Reduced 52.52%	21,951 $3.13 Million
Q2 2019 Aug 01, 2019	SELL	$157.85 - $183.09 $586,097 - $679,813	-3,713 Reduced 7.43%	46,231 $8.34 Million
Q1 2019 May 10, 2019	BUY	$89.33 - $163.65 $2.5 Million - $4.58 Million	27,980 Added 127.39%	49,944 $8.23 Million
Q4 2018 Feb 12, 2019	SELL	$81.94 - $139.71 $2.29 Million - $3.91 Million	-27,980 Reduced 56.02%	21,964 $1.93 Million
Q3 2018 Nov 09, 2018	BUY	$138.11 - $169.04 $3.96 Million - $4.85 Million	28,664 Added 134.7%	49,944 $0
Q2 2018 Aug 14, 2018	BUY	$140.36 - $175.76 $171,239 - $214,427	1,220 Added 6.08%	21,280 $3.23 Million
Q1 2018 May 03, 2018	SELL	$152.15 - $192.33 $6.6 Million - $8.35 Million	-43,390 Reduced 68.38%	20,060 $3.19 Million
Q3 2017 Nov 06, 2017	BUY	$61.4 - $88.52 $3.9 Million - $5.62 Million	63,450	63,450 $5.35 Million

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $325M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Account

Deka Bank Deutsche Girozentrale Sage Therapeutics, Inc. Transaction History